ENVESTNET ASSET MANAGEMENT INC - ULTRAGENYX PHARMACEUTICAL IN ownership

ULTRAGENYX PHARMACEUTICAL IN's ticker is RARE and the CUSIP is 90400D108. A total of 238 filers reported holding ULTRAGENYX PHARMACEUTICAL IN in Q2 2021. The put-call ratio across all filers is 1.29 and the average weighting 0.1%.

Quarter-by-quarter ownership
ENVESTNET ASSET MANAGEMENT INC ownership history of ULTRAGENYX PHARMACEUTICAL IN
ValueSharesWeighting
Q3 2023$1,278,266
-8.2%
35,856
+18.8%
0.00%0.0%
Q2 2023$1,392,250
+37.2%
30,181
+19.2%
0.00%
Q1 2023$1,015,051
-9.3%
25,313
+4.8%
0.00%
-100.0%
Q4 2022$1,119,379
+20.5%
24,161
+7.7%
0.00%0.0%
Q3 2022$929,000
-35.8%
22,428
-7.5%
0.00%0.0%
Q2 2022$1,446,000
-16.4%
24,237
+1.8%
0.00%0.0%
Q1 2022$1,730,000
+3.5%
23,817
+19.8%
0.00%0.0%
Q4 2021$1,672,000
+8.0%
19,878
+15.8%
0.00%0.0%
Q3 2021$1,548,000
+9.9%
17,169
+16.3%
0.00%0.0%
Q2 2021$1,408,000
-25.9%
14,765
-11.5%
0.00%0.0%
Q1 2021$1,901,000
+44.6%
16,692
+75.7%
0.00%0.0%
Q4 2020$1,315,000
+108.7%
9,499
+23.8%
0.00%0.0%
Q3 2020$630,000
+44.2%
7,670
+37.2%
0.00%
Q2 2020$437,000
+99.5%
5,590
+13.5%
0.00%
Q1 2020$219,000
+1360.0%
4,926
+1616.4%
0.00%
Q3 2017$15,000
-62.5%
287
-56.2%
0.00%
Q2 2017$40,000
-13.0%
656
-2.5%
0.00%
Q1 2017$46,000
+4.5%
673
+6.8%
0.00%
Q4 2016$44,0006300.00%
Other shareholders
ULTRAGENYX PHARMACEUTICAL IN shareholders Q2 2021
NameSharesValueWeighting ↓
EcoR1 Capital, LLC 497,899$31,617,0003.20%
HIGHLINE CAPITAL MANAGEMENT, L.P. 390,453$24,794,0001.81%
First Light Asset Management, LLC 180,017$11,431,0001.59%
Rock Springs Capital Management LP 580,000$36,830,0001.33%
Capital Impact Advisors, LLC 36,165$2,244,0000.82%
SECTOR GAMMA AS 79,653$5,058,0000.81%
Verity Asset Management, Inc. 7,193$457,0000.51%
Opus Point Partners Management, LLC 5,064$322,0000.48%
Capital International Sarl 52,000$3,302,0000.46%
PACIFIC VIEW ASSET MANAGEMENT, LLC 6,216$394,0000.43%
View complete list of ULTRAGENYX PHARMACEUTICAL IN shareholders